Human Fluids-Pathogen Interplay and its Impact on Cefidericol Susceptibility of Carbapenem-Resistant Acinetobacter Baumannii
Human Fluids-Pathogen Interplay and its Impact on Cefidericol Susceptibility of Carbapenem-Resistant Acinetobacter Baumannii
PCCLAT- BOLETÍN INFORMATIVO Nº61 – Julio 2022
BOLETIN INFORMATIVO Nº 61 – JULIO 2022 Estimados Colegas del “Programa Latinoamericano de Control de Calidad en Bacteriología y Resistencia a los Antimicrobianos”: En el presente BOLETIN INFORMATIVO Nº 61…
Emergence of Kpc Variants in Ceftazidime-Avibactam Resistant Klebsiella Pneumoniae Isolates from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97
Emergence of Kpc Variants in Ceftazidime-Avibactam Resistant Klebsiella Pneumoniae Isolates from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97 ASM MICROBE 9-13/6/2022, Washington, DC
PCCNAC- BOLETÍN INFORMATIVO N°4 – JUNIO 2022
BOLETIN INFORMATIVO Nº 4 – Junio 2022 Estimados colegas del Programa Nacional de Control de Calidad en Bacteriología (PCC-NAC): En el presente BOLETIN INFORMATIVO Nº4 enviamos: Alerta Epidemiológica Emergencia y…
Validation Of The Avibactam Agar Tests (avitest) To Determine Aztreonam Plus Avibactam (atm-avi) Susceptibility For Carbapenemase Producing Enterobacterales (cpe)
Validation Of The Avibactam Agar Tests (avitest) To Determine Aztreonam Plus Avibactam (atm-avi) Susceptibility For Carbapenemase Producing Enterobacterales (cpe) ASM MICROBE 9-13/6/2022, Washington, DC
Emergence during the COVID-19 pandemic of Klebsiella pneumoniae ST307 co-producing KPC-3 and NDM-1 carbapenemases
Emergence during the COVID-19 pandemic of Klebsiella pneumoniae ST307 co-producing KPC-3 and NDM-1 carbapenemases ASM MICROBE 9-13/6/2022, Washington, DC
Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in a ST235 Pseudomonas Aeruginosa Clinical Isolate from Argentina
Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in a ST235 Pseudomonas Aeruginosa Clinical Isolate from Argentina ASM MICROBE 9-13/6/2022, Washington, DC
PCCCar – INFORMATIVE NEWSLETTER Nº 24 – June 2022
Caribbean External Quality Assurance Program in Bacteriology and Antimicrobial Resistance (PCC-CAR) INFORMATIVE NEWSLETTER No. 24 – June 2022 Dear Colleagues of the «Caribbean External Quality Assurance Program in Bacteriology and…
PCCLAT- BOLETÍN INFORMATIVO Nº60 – Junio 2022
BOLETIN INFORMATIVO Nº 60 – JUNIO 2022 Estimados Colegas del “Programa Latinoamericano de Control de Calidad en Bacteriología y Resistencia a los Antimicrobianos”: En el presente BOLETIN INFORMATIVO Nº 60…
PCCNAC- BOLETÍN INFORMATIVO N°3 – MAYO 2022
BOLETIN INFORMATIVO Nº 3 – Mayo 2022 Estimados colegas del Programa Nacional de Control de Calidad en Bacteriología (PCC-NAC): En el presente BOLETIN INFORMATIVO Nº3 enviamos: Novedades CLSI 2022: resumen…
Acinetobacter baumannii response to cefiderocol challenge in human urine
Acinetobacter baumannii response to cefiderocol challenge in human urine
PCCCar – INFORMATIVE NEWSLETTER Nº 23 – May 2022
Caribbean External Quality Assurance Program in Bacteriology and Antimicrobial Resistance (PCC-CAR) INFORMATIVE NEWSLETTER No. 23 – May 2022 Dear Colleagues of the «Caribbean External Quality Assurance Program in Bacteriology and…
PCCLAT- BOLETÍN INFORMATIVO Nº59 – Mayo 2022
BOLETIN INFORMATIVO Nº 59 – MAYO 2022 Estimados Colegas del “Programa Latinoamericano de Control de Calidad en Bacteriología y Resistencia a los Antimicrobianos”: En el presente BOLETIN INFORMATIVO Nº59 enviamos:…
Aztreonam-avibactam susceptibility testing for carbapenemase-producing Enterobacterales (CPE) in the National Reference Laboratory (NRL): 2019-2021 surveillance results
Aztreonam-avibactam susceptibility testing for carbapenemase-producing Enterobacterales (CPE) in the National Reference Laboratory (NRL): 2019-2021 surveillance results. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -April 23-26 – Lisbon,…
Emergence of KPC variants from clinical origin associated with reduced susceptibility to ceftazidime- avibactam, including four novel blaKPC-2 variants
Emergence of KPC variants from clinical origin associated with reduced susceptibility to ceftazidime- avibactam, including four novel blaKPC-2 variants. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -April…
Carbapenemase-Producing Extraintestinal Pathogenic Escherichia coli From Argentina Clonal Diversity and Predominance of Hyperepidemic Clones CC10 and CC131
Carbapenemase-Producing Extraintestinal Pathogenic Escherichia coli From Argentina Clonal Diversity and Predominance of Hyperepidemic Clones CC10 and CC131
PCCCar – INFORMATIVE NEWSLETTER Nº 22 – April 2022
Caribbean External Quality Assurance Program in Bacteriology and Antimicrobial Resistance (PCC-CAR) INFORMATIVE NEWSLETTER No. 22 – April 2022 Dear Colleagues of the «Caribbean External Quality Assurance Program in Bacteriology and…
PCCNAC- BOLETÍN INFORMATIVO N°2 – ABRIL 2022
BOLETIN INFORMATIVO Nº 2 – Abril 2022 Estimados colegas del Programa Nacional de Control de Calidad en Bacteriología (PCC-NAC): En el presente BOLETIN INFORMATIVO Nº2 enviamos: WHO REPORT: Extensively drug-resistant…
Human Serum Proteins and susceptibility of Acinetobacter baumannii to cefiderocol: Role of iron transport
Human Serum Proteins and susceptibility of Acinetobacter baumannii to cefiderocol: Role of iron transport